A detailed history of First Republic Investment Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 1,275 shares of UTHR stock, worth $457,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,275
Previous 1,202 6.07%
Holding current value
$457,125
Previous $265,000 8.3%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$211.82 - $248.24 $15,462 - $18,121
73 Added 6.07%
1,275 $287,000
Q2 2023

Jul 28, 2023

SELL
$205.19 - $232.99 $333,844 - $379,074
-1,627 Reduced 57.51%
1,202 $265,000
Q1 2023

May 11, 2023

SELL
$212.99 - $276.17 $23,428 - $30,378
-110 Reduced 3.74%
2,829 $633,000
Q4 2022

Feb 13, 2023

SELL
$205.95 - $280.43 $46,956 - $63,938
-228 Reduced 7.2%
2,939 $817,000
Q3 2022

Nov 03, 2022

SELL
$203.3 - $244.17 $2,439 - $2,930
-12 Reduced 0.38%
3,167 $663,000
Q2 2022

Aug 16, 2022

SELL
$174.81 - $241.14 $58,910 - $81,264
-337 Reduced 9.58%
3,179 $749,000
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $45,029 - $57,983
271 Added 8.35%
3,516 $631,000
Q4 2021

Feb 09, 2022

BUY
$184.32 - $216.08 $336,015 - $393,913
1,823 Added 128.2%
3,245 $701,000
Q3 2021

Nov 12, 2021

BUY
$179.86 - $214.88 $24,101 - $28,793
134 Added 10.4%
1,422 $262,000
Q2 2021

Aug 16, 2021

SELL
$170.47 - $211.93 $90,690 - $112,746
-532 Reduced 29.23%
1,288 $231,000
Q1 2021

May 14, 2021

SELL
$153.94 - $174.85 $1,847 - $2,098
-12 Reduced 0.66%
1,820 $304,000
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $186,625 - $278,079
1,832 New
1,832 $278,000
Q3 2020

Nov 12, 2020

SELL
$99.9 - $121.13 $214,884 - $260,550
-2,151 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$92.74 - $125.82 $41,918 - $56,870
-452 Reduced 17.36%
2,151 $260,000
Q1 2020

May 13, 2020

BUY
$79.39 - $115.35 $206,652 - $300,256
2,603 New
2,603 $247,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.